Further, we have recently documented that CRISPR-mediated, agouti-related protein (AgRP) neuron-specific Tet3 ablation induces hyperphagia, systemic insulin resistance, obesity and type 2 diabetes [36]. The gene discussed is TET3; the disease is type 2 diabetes mellitus.